Bateman A - Search Results

1

Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.

Bateman A, Bullough F, Murphy S, Emiliusen L, Lavillette D, Cosset FL, Cattaneo R, Russell SJ, Vile RG. Bateman A, et al. Cancer Res. 2000 Mar 15;60(6):1492-7. Cancer Res. 2000. PMID: 10749110

2

Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.

Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Linardakis E, et al. Among authors: bateman a. Cancer Res. 2002 Oct 1;62(19):5495-504. Cancer Res. 2002. PMID: 12359759

3

Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.

Bateman AR, Harrington KJ, Kottke T, Ahmed A, Melcher AA, Gough MJ, Linardakis E, Riddle D, Dietz A, Lohse CM, Strome S, Peterson T, Simari R, Vile RG. Bateman AR, et al. Cancer Res. 2002 Nov 15;62(22):6566-78. Cancer Res. 2002. PMID: 12438252

4

Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity.

Melcher A, Todryk S, Bateman A, Chong H, Lemoine NR, Vile RG. Melcher A, et al. Among authors: bateman a. Cancer Res. 1999 Jun 15;59(12):2802-5. Cancer Res. 1999. PMID: 10383135

5

A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.

Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ, Vile RG. Diaz RM, et al. Among authors: bateman a. Gene Ther. 2000 Oct;7(19):1656-63. doi: 10.1038/sj.gt.3301277. Gene Ther. 2000. PMID: 11083474

6

Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.

Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ. Higuchi H, et al. Among authors: bateman a. Cancer Res. 2000 Nov 15;60(22):6396-402. Cancer Res. 2000. PMID: 11103804

7

Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.

Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ. Galanis E, et al. Among authors: bateman a. Hum Gene Ther. 2001 May 1;12(7):811-21. doi: 10.1089/104303401750148766. Hum Gene Ther. 2001. PMID: 11339897

8

Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.

Errington F, Bateman A, Kottke T, Thompson J, Harrington K, Merrick A, Hatfield P, Selby P, Vile R, Melcher A. Errington F, et al. Among authors: bateman a. Clin Cancer Res. 2006 Feb 15;12(4):1333-41. doi: 10.1158/1078-0432.CCR-05-1113. Clin Cancer Res. 2006. PMID: 16489091 Free article.

9

A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.

Emiliusen L, Gough M, Bateman A, Ahmed A, Voellmy R, Chester J, Diaz RM, Harrington K, Vile R. Emiliusen L, et al. Among authors: bateman a. Gene Ther. 2001 Jul;8(13):987-98. doi: 10.1038/sj.gt.3301470. Gene Ther. 2001. PMID: 11438833

10

Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.

Ahmed A, Jevremovic D, Suzuki K, Kottke T, Thompson J, Emery S, Harrington K, Bateman A, Vile R. Ahmed A, et al. Among authors: bateman a. Gene Ther. 2003 Sep;10(19):1663-71. doi: 10.1038/sj.gt.3302064. Gene Ther. 2003. PMID: 12923565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

935 results

Search Page

Filters